)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Cofoe Medical Technology
Cofoe Medical Technology (301087) investor relations material
Cofoe Medical Technology Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary29 Oct, 2026
Executive summary
Q3 revenue rose 24.07% YoY to RMB 1.119bn; net income attributable to shareholders increased 10.94% to RMB 102.98m. Nine-month revenue grew 33.08% to RMB 3.191bn and net income rose 17.30% to RMB 305.24m.
Growth was driven by higher sales of core categories, while increased online marketing, procurement and inventory weighed on expenses and operating cash flow.
Financial highlights
Nine-month adjusted net income, excluding non-recurring items, was RMB 269.52m, up 21.41% YoY; Q3 adjusted net income was RMB 96.93m, up 12.96%.
Nine-month non-recurring gains totaled RMB 35.72m, including government grants and fair-value gains on financial assets.
Nine-month selling expenses rose 47.18% to RMB 1.201bn; R&D expenses increased 30.82% to RMB 79.92m, primarily reflecting higher online promotion and R&D investment.
Nine-month financial expenses were RMB 9.56m versus income of RMB 3.77m a year earlier; foreign-exchange losses were RMB 21.458m.
Outlook and guidance
Procurement was increased in line with the annual operating plan and assessment of core-category market demand; prepayments to suppliers and inventory consequently increased.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Cofoe Medical Technology
- Q2 rebounded sharply, while H1 profit fell amid higher selling costs.301087
Q2 2024 - Profit and cash flow grew strongly as rehabilitation aids offset weaker monitoring and respiratory sales.301087Q4 2024
- Q3 earnings accelerated as 9M adjusted profit and operating cash flow grew.301087Q3 2024
- Overseas growth and stronger margins helped offset softer H1 revenue and earnings.301087Q2 2025
- Revenue, adjusted earnings and operating cash flow declined; acquisition and disposal effects shaped results.301087Q1 2025
- FY2025 growth accelerated in Q4 as overseas expansion and core health products gained momentum.301087Q4 2025
- Q3 growth accelerated as operating cash flow strengthened and an H-share listing application advanced.301087Q3 2025
- Revenue surged 38.5%, with respiratory products and overseas sales driving growth.301087Q2 2026
- Revenue surged 37.22%, while higher marketing costs and borrowing shaped Q1 performance.301087Q1 2026
Next Cofoe Medical Technology earnings date
Q4 202611 Mar, 2027
Cofoe Medical Technology
Next Cofoe Medical Technology earnings date
Q4 202611 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)